The treatment of cancer-induced anemia with erythropoietin-stimulating agents (ESAs ... In 2008, the Food and Drug Administration issued a black-box warning for both epoetin alfa and darbepoetin ...
Background: Erythropoietin stimulating agents (ESAs) are high-cost medications that have a significant impact on many pharmacy budgets. Recently, ESAs have received stronger safety warnings and ...
over its multi-billion dollar red blood cell-stimulating drug, erythropoietin (EPO). On January 19, Judge Young of the Federal District Court of Massachusetts ruled that TKT's gene-activated EPO ...
Drugs that stimulate the erythropoietin receptor (EpoR) can replenish red blood cells in cancer patients receiving chemotherapy. But, in 2007 and 2008, US and European regulators moved to restrict ...
Discover the commercial and brand names of the generic drug Erythropoietin. This indispensable guide is essential for healthcare professionals, patients, caregivers, and anyone seeking to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results